|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
US6242568B1
(en)
|
1994-01-18 |
2001-06-05 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
CA2196419C
(en)
|
1994-08-20 |
2007-08-21 |
Yen Choo |
Improvements in or relating to binding proteins for recognition of dna
|
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
|
US5789538A
(en)
|
1995-02-03 |
1998-08-04 |
Massachusetts Institute Of Technology |
Zinc finger proteins with high affinity new DNA binding specificities
|
|
US6699663B1
(en)
|
1995-12-14 |
2004-03-02 |
The General Hospital Corporation |
Molecular sequence of swine retrovirus
|
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
|
US5925523A
(en)
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
|
GB9703369D0
(en)
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
|
GB2338237B
(en)
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6503717B2
(en)
|
1999-12-06 |
2003-01-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
EP1083231A1
(en)
|
1999-09-09 |
2001-03-14 |
Introgene B.V. |
Smooth muscle cell promoter and uses thereof
|
|
AU2001250774B2
(en)
|
2000-02-08 |
2005-01-27 |
Sangamo Biosciences, Inc. |
Cells expressing zinc finger proteins for drug discovery
|
|
AU2001263155A1
(en)
|
2000-05-16 |
2001-11-26 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
|
US6627424B1
(en)
|
2000-05-26 |
2003-09-30 |
Mj Bioworks, Inc. |
Nucleic acid modifying enzymes
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7169874B2
(en)
|
2001-11-02 |
2007-01-30 |
Bausch & Lomb Incorporated |
High refractive index polymeric siloxysilane compositions
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
US7375234B2
(en)
|
2002-05-30 |
2008-05-20 |
The Scripps Research Institute |
Copper-catalysed ligation of azides and acetylenes
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
EP1636343B1
(en)
|
2003-05-28 |
2013-08-21 |
The Johns-Hopkins University |
Synthetic mammalian retrotransposon gene
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
KR100437889B1
(ko)
*
|
2003-08-26 |
2004-07-07 |
주식회사 인트론바이오테크놀로지 |
세망내피증 바이러스의 역전사 효소 및 이를 생산하는 방법
|
|
US7070941B2
(en)
|
2003-11-17 |
2006-07-04 |
Board Of Regents, The University Of Texas System |
Methods and compositions for tagging via azido substrates
|
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7253273B2
(en)
|
2004-04-08 |
2007-08-07 |
Sangamo Biosciences, Inc. |
Treatment of neuropathic pain with zinc finger proteins
|
|
ATE418346T1
(de)
|
2004-04-08 |
2009-01-15 |
Sangamo Biosciences Inc |
Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen
|
|
ES2547381T3
(es)
|
2004-04-09 |
2015-10-05 |
Monsanto Technology, Llc |
Composiciones y procedimientos de control de infestaciones de insectos en plantas
|
|
EP2397490B1
(en)
|
2004-07-16 |
2013-09-04 |
THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
|
|
DE102004034461B4
(de)
|
2004-07-16 |
2008-02-07 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren
|
|
ES2716864T3
(es)
|
2007-06-06 |
2019-06-17 |
Monsanto Technology Llc |
Genes y usos para la mejora de plantas
|
|
JP2011512326A
(ja)
|
2007-12-31 |
2011-04-21 |
ナノコア セラピューティクス,インコーポレイテッド |
心不全の治療用のrna干渉
|
|
US8394604B2
(en)
|
2008-04-30 |
2013-03-12 |
Paul Xiang-Qin Liu |
Protein splicing using short terminal split inteins
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
EP2937418B1
(en)
|
2008-10-20 |
2017-10-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of transthyretin
|
|
GB0901593D0
(en)
|
2009-01-30 |
2009-03-11 |
Touchlight Genetics Ltd |
Production of closed linear DNA
|
|
JP5882064B2
(ja)
|
2009-03-04 |
2016-03-09 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
安定化された逆転写酵素融合タンパク質
|
|
KR20220038506A
(ko)
|
2009-06-10 |
2022-03-28 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
AU2010325563B2
(en)
|
2009-11-27 |
2017-02-02 |
Basf Plant Science Company Gmbh |
Chimeric endonucleases and uses thereof
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
US8846883B2
(en)
|
2011-08-16 |
2014-09-30 |
University Of Southhampton |
Oligonucleotide ligation
|
|
PT2877490T
(pt)
|
2012-06-27 |
2019-02-12 |
Univ Princeton |
Inteínas clivadas, conjugados e suas utilizações
|
|
CN102723640B
(zh)
|
2012-07-09 |
2015-08-26 |
东莞中探探针有限公司 |
磁性连接器结构
|
|
CN105209621B
(zh)
*
|
2012-12-12 |
2021-05-25 |
布罗德研究所有限公司 |
对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
|
|
ES2887254T3
(es)
|
2013-03-08 |
2021-12-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
ES2749624T3
(es)
|
2013-03-14 |
2020-03-23 |
Caribou Biosciences Inc |
Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico
|
|
US10378026B2
(en)
*
|
2013-09-02 |
2019-08-13 |
Cellectis |
RNA based method to obtain stably integrated retroviral vectors
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
US10059655B2
(en)
|
2013-12-19 |
2018-08-28 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
US9663770B2
(en)
|
2014-01-22 |
2017-05-30 |
Life Technologies Corporation |
Reverse transcriptases for use in high temperature nucleic acid synthesis
|
|
CN113930455A
(zh)
|
2014-10-09 |
2022-01-14 |
生命技术公司 |
Crispr寡核苷酸和基因剪辑
|
|
DK3386484T3
(da)
|
2015-12-10 |
2022-07-04 |
Modernatx Inc |
Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
|
|
WO2017132580A2
(en)
|
2016-01-29 |
2017-08-03 |
The Trustees Of Princeton University |
Split inteins with exceptional splicing activity
|
|
EP3417062B1
(en)
|
2016-02-15 |
2024-06-26 |
Temple University - Of The Commonwealth System of Higher Education |
Excision of retroviral nucleic acid sequences
|
|
ES3030658T3
(en)
|
2016-03-30 |
2025-07-01 |
Intellia Therapeutics Inc |
Lipid nanoparticle formulations for crispr/cas components
|
|
US11427838B2
(en)
|
2016-06-29 |
2022-08-30 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
|
|
WO2018045321A1
(en)
|
2016-09-02 |
2018-03-08 |
North Carolina State University |
Methods and compositions for modification of plastid genomes
|
|
WO2018049075A1
(en)
|
2016-09-07 |
2018-03-15 |
Flagship Pioneering, Inc. |
Methods and compositions for modulating gene expression
|
|
US11280790B2
(en)
|
2016-10-04 |
2022-03-22 |
Svar Life Science Ab |
System and products for improved quantification of ADCC activity
|
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
US20190330620A1
(en)
|
2016-10-14 |
2019-10-31 |
Emendobio Inc. |
Rna compositions for genome editing
|
|
US20180127759A1
(en)
|
2016-10-28 |
2018-05-10 |
Massachusetts Institute Of Technology |
Dynamic genome engineering
|
|
WO2018089860A1
(en)
|
2016-11-11 |
2018-05-17 |
2D Genomics Inc. |
Methods for processing nucleic acid samples
|
|
US9816093B1
(en)
|
2016-12-06 |
2017-11-14 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
|
EP3551757A1
(en)
|
2016-12-08 |
2019-10-16 |
Intellia Therapeutics, Inc. |
Modified guide rnas
|
|
EP3596217A1
(en)
|
2017-03-14 |
2020-01-22 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
WO2019005955A1
(en)
|
2017-06-27 |
2019-01-03 |
Yale University |
ENHANCED REVERSE TRANSCRIPTASE AND METHODS OF USE THEREOF
|
|
WO2019040650A1
(en)
|
2017-08-23 |
2019-02-28 |
The General Hospital Corporation |
GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES HAVING MODIFIED PAM SPECIFICITY
|
|
CN111315889A
(zh)
|
2017-09-08 |
2020-06-19 |
生命技术公司 |
提高同源重组的方法和其组合物
|
|
EP3688162B1
(en)
|
2017-09-29 |
2024-03-06 |
Intellia Therapeutics, Inc. |
Formulations
|
|
IL311278B2
(en)
|
2017-09-29 |
2026-05-01 |
Intellia Therapeutics Inc |
Polynucleotides, compositions, and methods for genome editing
|
|
WO2019070843A1
(en)
|
2017-10-03 |
2019-04-11 |
Board Of Regents, The University Of Texas System |
INVERSE TRANSCRIPTASE WITH LTR-FREE BACKLIGHTS AND USES THEREOF
|
|
JP2021505159A
(ja)
|
2017-12-06 |
2021-02-18 |
ジェネレーション バイオ カンパニー |
修飾型閉端dna(cedna)を使用する遺伝子編集
|
|
CA3084825A1
(en)
|
2017-12-14 |
2019-06-20 |
Crispr Therapeutics Ag |
Novel rna-programmable endonuclease systems and their use in genome editing and other applications
|
|
US11293019B2
(en)
|
2017-12-22 |
2022-04-05 |
Gflas Life Sciences, Inc. |
Chimeric genome engineering molecules and methods
|
|
CA3092459A1
(en)
|
2018-03-02 |
2019-09-06 |
Generation Bio Co. |
Closed-ended dna (cedna) vectors for insertion of transgenes at genomic safe harbors (gsh) in humans and murine genomes
|
|
DK3765616T3
(da)
|
2018-03-14 |
2023-08-21 |
Arbor Biotechnologies Inc |
Nye enzymer og systemer målrettet crispr dna og rna
|
|
US11339385B2
(en)
|
2018-03-25 |
2022-05-24 |
GeneTether, Inc. |
Modified nucleic acid editing systems for tethering donor DNA
|
|
CA3104989A1
(en)
|
2018-03-27 |
2019-10-03 |
G+Flas Life Sciences |
Sequence-specific in vivo cell targeting
|
|
CA3105953A1
(en)
|
2018-07-09 |
2020-01-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
WO2020033083A1
(en)
|
2018-08-10 |
2020-02-13 |
Cornell University |
Optimized base editors enable efficient editing in cells, organoids and mice
|
|
AU2019327449B2
(en)
|
2018-08-28 |
2026-04-09 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
KR20210055733A
(ko)
|
2018-09-07 |
2021-05-17 |
빔 테라퓨틱스, 인크. |
핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
|
|
WO2020068897A1
(en)
|
2018-09-25 |
2020-04-02 |
Massachusetts Institute Of Technology |
Engineered dcas9 with reduced toxicity and its use in genetic circuits
|
|
CA3121191A1
(en)
|
2018-11-28 |
2020-06-04 |
Crispr Therapeutics Ag |
Optimized mrna encoding cas9 for use in lnps
|
|
JP7646552B2
(ja)
|
2019-01-31 |
2025-03-17 |
ビーム セラピューティクス インク. |
低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ
|
|
SG11202108812SA
(en)
*
|
2019-02-15 |
2021-09-29 |
Sigma Aldrich Co Llc |
Crispr/cas fusion proteins and systems
|
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020241869A1
(ja)
*
|
2019-05-30 |
2020-12-03 |
国立大学法人東京大学 |
2種の核酸塩基変換酵素が融合されたCasタンパク質を利用したゲノム編集システム
|
|
US20220298495A1
(en)
|
2019-06-12 |
2022-09-22 |
Emendobio Inc. |
Novel genome editing tool
|
|
CA3147875A1
(en)
|
2019-07-19 |
2021-01-28 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
WO2021042047A1
(en)
|
2019-08-30 |
2021-03-04 |
The General Hospital Corporation |
C-to-g transversion dna base editors
|
|
EP4034659A4
(en)
|
2019-09-27 |
2024-10-16 |
The Broad Institute, Inc. |
PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR AMPLIFIED HOMOLOGOUS RECOMBINATION
|
|
WO2021080922A1
(en)
*
|
2019-10-21 |
2021-04-29 |
The Trustees Of Columbia University In The City Of New York |
Methods of performing rna templated genome editing
|
|
JP7785002B2
(ja)
*
|
2019-11-05 |
2025-12-12 |
ペアーワイズ プランツ サービシズ, インコーポレイテッド |
対立遺伝子のrnaにコードされたdnaの置換のための組成物および方法
|
|
EP4061940A4
(en)
|
2019-11-22 |
2024-10-23 |
Flagship Pioneering Innovations VI, LLC |
RECOMBINASE COMPOSITIONS AND METHODS OF USE
|
|
US20230051661A1
(en)
|
2019-12-26 |
2023-02-16 |
Agency For Science, Technology And Research |
Nucleobase Editors
|
|
WO2021138469A1
(en)
*
|
2019-12-30 |
2021-07-08 |
The Broad Institute, Inc. |
Genome editing using reverse transcriptase enabled and fully active crispr complexes
|
|
BR112022017715A2
(pt)
|
2020-03-04 |
2022-11-16 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições para modular um genoma
|
|
AU2021232005A1
(en)
|
2020-03-04 |
2022-09-29 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
IL296095A
(en)
|
2020-03-04 |
2022-11-01 |
Flagship Pioneering Innovations Vi Llc |
Improved methods and compositions for genome modulation
|
|
US20230348939A1
(en)
|
2020-03-04 |
2023-11-02 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
BR112022017735A2
(pt)
|
2020-03-05 |
2022-11-29 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições de supressão de defesa de hospedeiro para modular um genoma
|
|
WO2021188840A1
(en)
|
2020-03-19 |
2021-09-23 |
Rewrite Therapeutics, Inc. |
Methods and compositions for directed genome editing
|
|
CN115427566A
(zh)
|
2020-04-08 |
2022-12-02 |
阿斯利康(瑞典)有限公司 |
用于改善的位点特异性修饰的组合物和方法
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
WO2021248102A1
(en)
|
2020-06-05 |
2021-12-09 |
Flagship Pioneering Innovations Vi, Llc |
Template guide rna molecules
|
|
AU2021403660A1
(en)
|
2020-12-16 |
2023-07-06 |
Universitat Pompeu Fabra |
Programmable transposases and uses thereof
|
|
AU2022206476A1
(en)
|
2021-01-11 |
2023-07-20 |
President And Fellows Of Harvard College |
Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
|
|
CN116745428A
(zh)
|
2021-01-14 |
2023-09-12 |
加利福尼亚大学董事会 |
位点特异性基因修饰
|
|
WO2022155532A1
(en)
|
2021-01-15 |
2022-07-21 |
4M Genomics Inc. |
Polypeptide fusions or conjugates for gene editing
|
|
KR102876548B1
(ko)
|
2021-01-21 |
2025-10-30 |
한국생명공학연구원 |
Francisella novicida Cas9 모듈 기반의 역전사 효소를 사용한 유전체 치환 및 삽입 기술
|
|
US20230374476A1
(en)
|
2021-02-05 |
2023-11-23 |
University Of Massachusetts |
Prime editor system for in vivo genome editing
|
|
US20240132916A1
(en)
|
2021-02-09 |
2024-04-25 |
The Broad Institute, Inc. |
Nuclease-guided non-ltr retrotransposons and uses thereof
|
|
WO2022183210A1
(en)
|
2021-02-26 |
2022-09-01 |
Flagship Pioneering Innovations Vi, Llc |
Tissue-specific methods and compositions for modulating a genome
|
|
EP4314257A4
(en)
|
2021-04-01 |
2025-07-09 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
|
|
EP4352230A4
(en)
|
2021-06-03 |
2025-06-11 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treating Wilson's disease
|
|
WO2023283092A1
(en)
|
2021-07-06 |
2023-01-12 |
Prime Medicine, Inc. |
Compositions and methods for efficient genome editing
|
|
WO2023004439A2
(en)
|
2021-07-23 |
2023-01-26 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of chronic granulomatous disease
|
|
WO2023015318A2
(en)
|
2021-08-05 |
2023-02-09 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of cystic fibrosis
|
|
US20240360476A1
(en)
|
2021-08-05 |
2024-10-31 |
Prime Medicine, Inc. |
Genome Editing Compositions and Methods for Treatment of Myotonic Dystrophy
|
|
AU2022325166A1
(en)
|
2021-08-06 |
2024-02-08 |
President And Fellows Of Harvard College |
Improved prime editors and methods of use
|
|
WO2023039447A2
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Serpina-modulating compositions and methods
|
|
CA3231712A1
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Pah-modulating compositions and methods
|
|
KR20260037664A
(ko)
|
2021-09-08 |
2026-03-18 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
게놈을 조절하기 위한 방법 및 조성물
|
|
WO2023039586A1
(en)
|
2021-09-10 |
2023-03-16 |
Agilent Technologies, Inc. |
Guide rnas with chemical modification for prime editing
|
|
US20240425831A1
(en)
|
2021-10-08 |
2024-12-26 |
The General Hospital Corporation |
Improved crispr prime editors
|
|
CA3235826A1
(en)
|
2021-10-21 |
2023-04-27 |
Wei Hsi Yeh |
Genome editing compositions and methods for treatment of usher syndrome type 3
|
|
US20250011766A1
(en)
|
2021-11-09 |
2025-01-09 |
Prime Medicine, Inc. |
Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
|
|
US20250319202A1
(en)
|
2021-11-09 |
2025-10-16 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
|
|
EP4430189A1
(en)
|
2021-11-11 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fragile x syndrome
|
|
US20250297248A1
(en)
|
2021-11-24 |
2025-09-25 |
Prime Medicine, Inc. |
Methods and compositions for inhibiting mismatch repair
|
|
AU2022398241A1
(en)
|
2021-11-24 |
2024-06-06 |
Prime Medicine, Inc. |
Modified prime editing guide rnas
|
|
EP4444362A4
(en)
|
2021-12-10 |
2026-04-01 |
Flagship Pioneering Innovations Vi Llc |
CFTR COMPOSITIONS AND MODULATION METHODS
|
|
WO2023192655A2
(en)
|
2022-04-01 |
2023-10-05 |
Prime Medicine, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
CA3260587A1
(en)
*
|
2022-06-24 |
2023-12-28 |
Flagship Pioneering Innovations Vi, Llc |
FAH COMPOSITIONS AND MODULATION METHODS
|